HIV Drug PK Data Correlation To Clinical Outcomes Needs Study - FDA Cmte.
Executive Summary
The relationship between antiretroviral pharmacokinetic data and virologic outcomes needs to be studied further if new HIV drug regimens are to be approved based on pharmacokinetic data, the Antiviral Drugs Advisory Committee indicated at a July 25 meeting.